Prosight Management, LP Meira G Tx Holdings PLC Transaction History

Prosight Management, LP

  • $281 Million
  • Q1 2025

A detailed history of Prosight Management, LP transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Prosight Management, LP holds 3,691,546 shares of MGTX stock, worth $24.5 Million. This represents 8.91% of its overall portfolio holdings.

Number of Shares
3,691,546
Previous 4,390,837 15.93%
Holding current value
$24.5 Million
Previous $26.7 Million 6.4%
% of portfolio
8.91%
Previous 7.94%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$5.71 - $8.25 $3.99 Million - $5.77 Million
-699,291 Reduced 15.93%
3,691,546 $25 Million
Q4 2024

Feb 14, 2025
SELL
$4.03 - $7.1 $2.05 Million - $3.62 Million
-509,733 Reduced 10.4%
4,390,837 $26.7 Million
Q3 2024

Nov 14, 2024
BUY
$3.88 - $5.23 $2.13 Million - $2.87 Million
547,870 Added 12.59%
4,900,570 $20.4 Million
Q2 2024

Aug 14, 2024
BUY
$4.21 - $5.81 $1.41 Million - $1.95 Million
335,399 Added 8.35%
4,352,700 $18.3 Million
Q1 2024

May 15, 2024
SELL
$5.78 - $7.33 $193,127 - $244,917
-33,413 Reduced 0.82%
4,017,301 $24.4 Million
Q4 2023

Feb 14, 2024
SELL
$3.6 - $7.15 $101,124 - $200,843
-28,090 Reduced 0.69%
4,050,714 $28.4 Million
Q2 2023

Aug 14, 2023
SELL
$5.19 - $8.07 $503,788 - $783,346
-97,069 Reduced 6.52%
1,391,848 $9.35 Million
Q2 2023

Aug 14, 2023
BUY
$5.19 - $8.07 $13.9 Million - $21.7 Million
2,686,956 Added 193.05%
4,078,804 $27.4 Million
Q1 2023

May 12, 2023
SELL
$5.04 - $8.6 $728,930 - $1.24 Million
-144,629 Reduced 8.85%
1,488,917 $7.7 Million
Q4 2022

Feb 14, 2023
BUY
$5.8 - $8.98 $3.08 Million - $4.76 Million
530,181 Added 48.05%
1,633,546 $10.7 Million
Q3 2022

Nov 14, 2022
BUY
$7.55 - $11.25 $884,459 - $1.32 Million
117,147 Added 11.88%
1,103,365 $9.28 Million
Q2 2022

Aug 12, 2022
BUY
$6.8 - $14.23 $4.12 Million - $8.62 Million
605,518 Added 159.05%
986,218 $7.47 Million
Q1 2022

May 16, 2022
BUY
$13.42 - $23.38 $5.11 Million - $8.9 Million
380,700 New
380,700 $5.27 Million
Q4 2021

Feb 14, 2022
SELL
$12.78 - $23.74 $3.72 Million - $6.91 Million
-291,080 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$11.73 - $16.08 $205,943 - $282,316
17,557 Added 6.42%
291,080 $3.84 Million
Q2 2021

Aug 13, 2021
SELL
$12.85 - $16.2 $236,709 - $298,420
-18,421 Reduced 6.31%
273,523 $4.24 Million
Q1 2021

May 14, 2021
SELL
$13.84 - $17.8 $1.23 Million - $1.59 Million
-89,175 Reduced 23.4%
291,944 $4.21 Million
Q4 2020

Feb 12, 2021
SELL
$12.4 - $17.6 $123,752 - $175,648
-9,980 Reduced 2.55%
381,119 $5.77 Million
Q3 2020

Nov 13, 2020
SELL
$11.59 - $14.93 $1.49 Million - $1.92 Million
-128,868 Reduced 24.78%
391,099 $5.18 Million
Q2 2020

Aug 14, 2020
SELL
$11.79 - $15.97 $570,411 - $772,644
-48,381 Reduced 8.51%
519,967 $6.51 Million
Q1 2020

May 15, 2020
BUY
$9.31 - $21.24 $470,192 - $1.07 Million
50,504 Added 9.75%
568,348 $7.64 Million
Q4 2019

Feb 14, 2020
BUY
$13.91 - $21.48 $2.5 Million - $3.86 Million
179,748 Added 53.16%
517,844 $10.4 Million
Q3 2019

Nov 14, 2019
BUY
$15.84 - $30.01 $5.36 Million - $10.1 Million
338,096 New
338,096 $5.39 Million
Q2 2019

Aug 14, 2019
SELL
$17.38 - $26.88 $1.59 Million - $2.45 Million
-91,317 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$9.2 - $21.21 $840,116 - $1.94 Million
91,317 New
91,317 $1.57 Million
Q4 2018

Feb 14, 2019
SELL
$9.61 - $14.02 $372,349 - $543,218
-38,746 Closed
0 $0
Q3 2018

Nov 15, 2018
BUY
$8.1 - $13.6 $313,842 - $526,945
38,746 New
38,746 $527,000

Others Institutions Holding MGTX

# of Institutions
119
Shares Held
47.3M
Call Options Held
159K
Put Options Held
38.4K
View Full List

About MeiraGTx Holdings plc

MGTX Quotes by TradingView
  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $298M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email